Literature DB >> 29240594

Preventive Effect of a Microclimate-Regulating System on Pressure Ulcer Development: A Prospective, Randomized Controlled Trial in Dutch Nursing Homes.

Martin van Leen1, Ruud Halfens, Jos Schols.   

Abstract

OBJECTIVE: Prevention of pressure ulcers (PrUs) is based on relieving pressure, diminishing shear stress, and controlling the skin's microclimate. Based on the recommendations in the most recent guideline for prevention of PrUs, a pressure-relieving, shear stress-diminishing, and microclimate-controlling skin interface multilayer support system (Bedcare; Sense Textile, 's-Hertogenbosch, the Netherlands) has been developed for use on top of a viscoelastic foam mattress (Formafoam, Kabelfabriek Eupen, Belgium). The aim of this study was to test the PrU preventive effect of this system compared with a viscoelastic foam mattress alone.
METHODS: A multicenter, prospective, randomized controlled trial was executed in 21 nursing homes in the Netherlands. Residents with a Braden score less than 16, a life expectancy of more than 3 months, and no PrUs during the last 3 months were asked to participate and included after informed consent. Residents were divided into 2 groups. The control group received a new high-quality viscoelastic foam mattress covered with a cotton sheet. The intervention group received the same new mattress, in combination with the newly developed multilayer system. Research nurses followed the participating residents for 12 weeks. The outcome parameter was the development of PrUs.
RESULTS: Two hundred six residents participated in the study. Both groups had comparable demographics (eg, age, Braden score, care dependency, incontinence). In the control group, 5% of the residents developed a category 2, 3, or 4 PrU, and 9% in the intervention group did. These results were not statistically significant.
CONCLUSIONS: This study shows that the multilayer system (Mini Overlay System, barrier mattress cover, and Stay and Transfer Sheet), when used as an integral system and in combination with a viscoelastic foam mattress, has no added value over the viscoelastic foam mattress/cotton sheet.

Entities:  

Mesh:

Year:  2018        PMID: 29240594     DOI: 10.1097/01.ASW.0000527288.35840.0a

Source DB:  PubMed          Journal:  Adv Skin Wound Care        ISSN: 1527-7941            Impact factor:   2.347


  7 in total

1.  Alternating pressure (active) air surfaces for preventing pressure ulcers.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Sarah Rhodes; Asmara Jammali-Blasi; Elizabeth McInnes
Journal:  Cochrane Database Syst Rev       Date:  2021-05-10

2.  Alternative reactive support surfaces (non-foam and non-air-filled) for preventing pressure ulcers.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Sarah Rhodes; Elizabeth McInnes
Journal:  Cochrane Database Syst Rev       Date:  2021-05-06

3.  Beds, overlays and mattresses for treating pressure ulcers.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Sarah Rhodes; Asmara Jammali-Blasi; Victoria Ramsden; Elizabeth McInnes
Journal:  Cochrane Database Syst Rev       Date:  2021-05-10

4.  Reactive air surfaces for preventing pressure ulcers.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Sarah Rhodes; Vannessa Leung; Elizabeth McInnes
Journal:  Cochrane Database Syst Rev       Date:  2021-05-07

5.  Effect of Hospital Linens on Unit-Acquired Pressure Injuries for Adults in Medical ICUs: A Cluster Randomized Controlled Trial.

Authors:  Mary Montague-McCown; James Bena; Christian N Burchill
Journal:  Crit Care Explor       Date:  2021-02-24

6.  Foam surfaces for preventing pressure ulcers.

Authors:  Chunhu Shi; Jo C Dumville; Nicky Cullum; Sarah Rhodes; Elizabeth McInnes
Journal:  Cochrane Database Syst Rev       Date:  2021-05-06

7.  Predicting the cut-off point for interface pressure in pressure injury according to the standard hospital mattress and polyurethane foam mattress as support surfaces.

Authors:  Mi Yu; Kyung Hee Park; Jiseon Shin; Ji Hyun Lee
Journal:  Int Wound J       Date:  2022-02-02       Impact factor: 3.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.